Up a level |
Chan, Stephen L, Mo, Frankie, Johnson, Philip ORCID: 0000-0003-1404-0209, Li, Leung, Tang, Nelson, Loong, Herbert, Chan, Anthony WH, Koh, Jane, Chan, Anthony TC and Yeo, Winnie
(2015)
Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30 (10).
pp. 1529-1535.
Chan, Anthony WH, Chong, Charing CN, Mo, Frankie KF, Wong, John, Yeo, Winnie, Johnson, Philip J ORCID: 0000-0003-1404-0209, Yu, Shuangni, Lai, Paul BS, Chan, Anthony TC, To, Ka-Fai et al (show 1 more authors)
(2016)
Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 31 (10).
pp. 1766-1772.
Vogel, Arndt, Frenette, Catherine, Sung, Max, Daniele, Bruno, Baron, Ari, Chan, Stephen L, Blanc, Jean Frederic, Tamai, Toshiyuki, Ren, Min, Lim, Howard J et al (show 3 more authors)
(2021)
Baseline Liver Function and Subsequent Outcomes in the Phase 3 REFLECT Study of Patients with Unresectable Hepatocellular Carcinoma.
LIVER CANCER, 10 (5).
pp. 510-521.
Kudo, Masatoshi, Galle, Peter R, Brandi, Giovanni, Kang, Yoon-Koo, Yen, Chia-Jui, Finn, Richard S, Llovet, Josep M, Assenat, Eric, Merle, Philippe, Chan, Stephen L et al (show 11 more authors)
(2021)
Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2.
JHEP REPORTS, 3 (2).
100215-.
Chan, Anthony WH, Chong, Charing CN, Mo, Frankie KF, Wong, John, Yeo, Winnie, Johnson, Philip J ORCID: 0000-0003-1404-0209, Yu, Shuangni, Lai, Paul BS, Chan, Anthony TC, To, Ka-Fai et al (show 1 more authors)
(2017)
Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 32 (1).
pp. 221-228.
Chong, Charing CN, Lee, Kit-Fai, Chu, Cheuk-Man, Chan, Anthony WH, Wong, John, Chan, Stephen L, Lok, Hon-Ting, Fung, Andrew KY, Fong, Anthony KW, Cheung, Yue S et al (show 3 more authors)
(2018)
Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection.
HPB, 20 (6).
pp. 546-554.
Verset, Gontran, Borbath, Ivan, Karwal, Mark, Verslype, Chris, Van Vlierberghe, Hans, Kardosh, Adel, Zagonel, Vittorina, Stal, Per, Sarker, Debashis, Palmer, Daniel H ORCID: 0000-0002-7147-5703 et al (show 16 more authors)
(2022)
Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial.
CLINICAL CANCER RESEARCH, 28 (12).
pp. 2547-2554.
Han, Guohong, Berhane, Sarah, Toyoda, Hidenori, Bettinger, Dominik, Elshaarawy, Omar, Chan, Anthony WH, Kirstein, Martha, Mosconi, Cristina, Hucke, Florian, Palmer, Daniel ORCID: 0000-0002-7147-5703 et al (show 24 more authors)
(2020)
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach.
Hepatology (Baltimore, Md.), 72 (01).
pp. 198-212.
Berhane, Sarah, Toyoda, Hidenori, Tada, Toshifumi, Kumada, Takashi, Kagebayashi, Chiaki, Satomura, Shinji, Schweitzer, Nora, Vogel, Arndt, Manns, Michael P, Benckert, Julia et al (show 15 more authors)
(2016)
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 14 (6).
875-+.
Waked, Imam, Berhane, Sarah, Toyoda, Hidenori, Chan, Stephen L, Stern, Nicholas, Palmer, Daniel ORCID: 0000-0002-7147-5703, Tada, Toshifumi, Yeo, Winnie, Mo, Frankie, Bettinger, Dominik et al (show 9 more authors)
(2017)
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion.
BRITISH JOURNAL OF CANCER, 116 (4).
pp. 448-454.
Kudo, Masatoshi, Finn, Richard S, Edeline, Julien, Cattan, Stephane, Ogasawara, Sadahisa, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Verslype, Chris, Zagonel, Vittorina, Fartoux, Laetitia, Vogel, Arndt et al (show 11 more authors)
(2022)
Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib.
EUROPEAN JOURNAL OF CANCER, 167.
pp. 1-12.